Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Hillstream BioPharma Progressing Towards Acquiring Clinical Stage Asset And Announces Corporate Name Change To Tharimmune; Stock To Trade On Nasdaq Under "THAR" Effective Sept. 25

Author: Benzinga Newsdesk | September 22, 2023 09:06am

Expects to launch and complete a Phase 1 trial in Q4 2023

Tharimmune to begin trading under new ticker, THAR, on Monday September 25, 2023

Posted In: HILS